BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 11550149)

  • 1. Loss of heterozygosity on chromosome 13q12-q14, BRCA-2 mutations and lack of BRCA-2 promoter hypermethylation in sporadic epithelial ovarian tumors.
    Gras E; Cortes J; Diez O; Alonso C; Matias-Guiu X; Baiget M; Prat J
    Cancer; 2001 Aug; 92(4):787-95. PubMed ID: 11550149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of heterozygosity on chromosome 17q in epithelial ovarian tumors: association with carcinomas with serous differentiation.
    Garcia A; Bussaglia E; Machin P; Matias-Guiu X; Prat J
    Int J Gynecol Pathol; 2000 Apr; 19(2):152-7. PubMed ID: 10782412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic and germline mutations of the BRCA2 gene in sporadic ovarian cancer.
    Foster KA; Harrington P; Kerr J; Russell P; DiCioccio RA; Scott IV; Jacobs I; Chenevix-Trench G; Ponder BA; Gayther SA
    Cancer Res; 1996 Aug; 56(16):3622-5. PubMed ID: 8705994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation not a frequent "second hit" in tumors with germline BRCA mutations.
    Dworkin AM; Spearman AD; Tseng SY; Sweet K; Toland AE
    Fam Cancer; 2009; 8(4):339-46. PubMed ID: 19340607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic mutations in the BRCA2 gene and high frequency of allelic loss of BRCA2 in sporadic male breast cancer.
    Kwiatkowska E; Teresiak M; Breborowicz D; Mackiewicz A
    Int J Cancer; 2002 Apr; 98(6):943-5. PubMed ID: 11948477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypermethylation of fragile histidine triad gene and 3p14 allelic deletion in ovarian carcinomas].
    Hong FZ; Wang B; Li HM; Liew CT
    Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):257-61. PubMed ID: 16181544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations of the BRCA2 gene in ovarian carcinomas.
    Takahashi H; Chiu HC; Bandera CA; Behbakht K; Liu PC; Couch FJ; Weber BL; LiVolsi VA; Furusato M; Rebane BA; Cardonick A; Benjamin I; Morgan MA; King SA; Mikuta JJ; Rubin SC; Boyd J
    Cancer Res; 1996 Jun; 56(12):2738-41. PubMed ID: 8665505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome 8p alterations in sporadic and BRCA2 999del5 linked breast cancer.
    Sigbjörnsdottir BI; Ragnarsson G; Agnarsson BA; Huiping C; Barkardottir RB; Egilsson V; Ingvarsson S
    J Med Genet; 2000 May; 37(5):342-7. PubMed ID: 10807692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node metastasis is associated with allelic loss on chromosome 13q12-13 in esophageal squamous cell carcinoma.
    Harada H; Tanaka H; Shimada Y; Shinoda M; Imamura M; Ishizaki K
    Cancer Res; 1999 Aug; 59(15):3724-9. PubMed ID: 10446988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13q12-q13.
    Cleton-Jansen AM; Collins N; Lakhani SR; Weissenbach J; Devilee P; Cornelisse CJ; Stratton MR
    Br J Cancer; 1995 Nov; 72(5):1241-4. PubMed ID: 7577475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene.
    Wang C; Horiuchi A; Imai T; Ohira S; Itoh K; Nikaido T; Katsuyama Y; Konishi I
    J Pathol; 2004 Feb; 202(2):215-23. PubMed ID: 14743504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping loss of heterozygosity at chromosome 13q: loss at 13q12-q13 is associated with breast tumour progression and poor prognosis.
    Eiriksdottir G; Johannesdottir G; Ingvarsson S; Björnsdottir IB; Jonasson JG; Agnarsson BA; Hallgrimsson J; Gudmundsson J; Egilsson V; Sigurdsson H; Barkardottir RB
    Eur J Cancer; 1998 Dec; 34(13):2076-81. PubMed ID: 10070314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas.
    Freihoff D; Kempe A; Beste B; Wappenschmidt B; Kreyer E; Hayashi Y; Meindl A; Krebs D; Wiestler OD; von Deimling A; Schmutzler RK
    Br J Cancer; 1999 Feb; 79(5-6):754-8. PubMed ID: 10070865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allelic loss at BRCA1, BRCA2, and adjacent loci in relation to TP53 abnormality in breast cancer.
    Tseng SL; Yu IC; Yue CT; Chang SF; Chang TM; Wu CW; Shen CY
    Genes Chromosomes Cancer; 1997 Dec; 20(4):377-82. PubMed ID: 9408754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity at chromosome segment Xq25-26.1 in advanced human ovarian carcinomas.
    Choi C; Cho S; Horikawa I; Berchuck A; Wang N; Cedrone E; Jhung SW; Lee JB; Kerr J; Chenevix-Trench G; Kim S; Barrett JC; Koi M
    Genes Chromosomes Cancer; 1997 Nov; 20(3):234-42. PubMed ID: 9365830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A common region of deletion on chromosome 17q in both sporadic and familial epithelial ovarian tumors distal to BRCA1.
    Godwin AK; Vanderveer L; Schultz DC; Lynch HT; Altomare DA; Buetow KH; Daly M; Getts LA; Masny A; Rosenblum N
    Am J Hum Genet; 1994 Oct; 55(4):666-77. PubMed ID: 7942844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent loss of heterozygosity at chromosome 13q12-13 with BRCA2 markers in sporadic male breast cancer.
    Prechtel D; Werenskiold AK; Prechtel K; Keller G; Höfler H
    Diagn Mol Pathol; 1998 Feb; 7(1):57-62. PubMed ID: 9646036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.
    Esteller M; Silva JM; Dominguez G; Bonilla F; Matias-Guiu X; Lerma E; Bussaglia E; Prat J; Harkes IC; Repasky EA; Gabrielson E; Schutte M; Baylin SB; Herman JG
    J Natl Cancer Inst; 2000 Apr; 92(7):564-9. PubMed ID: 10749912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas.
    Dodson MK; Hartmann LC; Cliby WA; DeLacey KA; Keeney GL; Ritland SR; Su JQ; Podratz KC; Jenkins RB
    Cancer Res; 1993 Oct; 53(19):4456-60. PubMed ID: 8402612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular evidence for putative tumour suppressor genes on chromosome 13q specific to BRCA1 related ovarian and fallopian tube cancer.
    Jongsma AP; Piek JM; Zweemer RP; Verheijen RH; Klein Gebbinck JW; van Kamp GJ; Jacobs IJ; Shaw P; van Diest PJ; Kenemans P
    Mol Pathol; 2002 Oct; 55(5):305-9. PubMed ID: 12354934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.